Electrosurgery

(redirected from Bovie)
Also found in: Dictionary, Thesaurus, Medical.

electrosurgery

[i¦lek·trō′sərj·ə·rē]
(medicine)
The use of electricity to perform surgical procedures, as the use of electricity to simultaneously cut tissue and arrest bleeding.

Electrosurgery

 

surgery involving the application of a high-frequency current (hundreds of thousands of oscillations per second) to tissues, with a sharp elevation of temperature at the point of contact between the active electrode and the tissues.

A distinction is made between electrotomy, the separation and excision of tissues, and electrocoagulation, the cauterization (coagulation of proteins) of tissues. Incision of tissues with an electric knife does not cause bleeding because the blood coagulates along the incision. Electrosurgical methods are used in operations on the brain (the bloodless operative field permits visual control of the operation) and eyes. They are also used to remove skin tumors and in dentistry.

References in periodicals archive ?
Bovie Medical Corporation manufactures and supplies medical devices.
uses the Bovie rather than a knife or scissors when performing the initial circumferential incision around the cervix in a vaginal hysterectomy.
Bovie Medical is in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the company's own well-respected brands (Bovie, Aaron, IDS and ICON) to distributors worldwide.
Bovie Medical is also engaged in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the company's own brands to distributors worldwide.
Bovie, through its wholly owned subsidiary, Aaron Medical Industries, is engaged in the engineering, manufacturing and marketing of electrosurgical medical products.
US-based medical device company Bovie Medical Corp.
Medical devices company Bovie Medical (NYSE MKT:BVX) revealed on Tuesday the completion of the acquisition of its Bulgarian R&D and manufacturing contractor (Bovie Bulgaria) for about EUR500,000 in cash and payable over a five-year period.
During the first three months of 2012, Bovie experienced increases in sales across all product lines and this trend has continued into the second quarter.
Medical devices company Bovie Medical (NYSE:BVX) said on Thursday that it has priced its public offering of 4,800,000 shares of its common stock.
Bovie Medical Corporation ("Bovie" or the "Company") (NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced that its board of directors has completed its review of recent allegations and disclosures concerning the Company's Chief Operating Officer, Mr.
M2 PHARMA-October 21, 2015-Bovie Medical buys its Bulgarian R&D and manufacturing contractor, Bovie Bulgaria
Medical device company Bovie Medical (NYSEMKT:BVX) said on Wednesday that it intends to launch its registered underwritten public offering of its common stock.